Carlsmed Inc
Veridion Score
Composite trend over time
Why is CARL moving today?
Carlsmed Inc is a commercial-stage medical technology company focused on developing AI-enabled personalized solutions for spine surgery. The company operates as a single operating and reportable segment engaged in the design, manufacture, and marketing of its Aprevo technology platform, which provides customized surgical planning and implants for lumbar and cervical spine fusion procedures, mainly sold to hospitals and ambulatory surgical centers.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for CARL.
CARL insider activity
Carlsmed Inc
No multi-insider buying cluster in the last 90 days
Net selling: -$2.4M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | 2026-03-03 | Cordonnier Michael | Insider | buy | $4.35 | 33,264 | 1,550,477 | $145K | SEC Form 4 |
| 2026-03-04 | 2026-03-03 | Cordonnier Michael | Insider | buy | $0.34 | 160,567 | 1,517,213 | $54K | SEC Form 4 |
| 2026-03-04 | 2026-03-02 | Cordonnier Michael | Insider | sell | $13.29 | 197,855 | 1,356,646 | $2.6M | SEC Form 4 |
| 2026-03-04 | 2026-03-02 | Cordonnier Michael | Insider | buy | $0.34 | 197,855 | 1,554,501 | $66K | SEC Form 4 |
CARL contract awards, year to date.
Public federal awards linked to this ticker.
CARL lobbying filings, year to date.
Registered lobbying filings matched to Carlsmed Inc.